Reassessing Novo Nordisk (CPSE:NOVO B) After Sharp Share Price Declines
- If you are looking at Novo Nordisk and wondering whether the current share price still lines up with the company’s long term story, you are not alone.
- The stock last closed at DKK 238.6, with returns of 22.4% decline over 7 days, 39.4% decline over 30 days, 27.8% decline year to date, 61.8% decline over 1 year and 50.0% decline over 3 years, while the 5 year return stands at 19.6%.
- These swings have arrived alongside ongoing attention on Novo Nordisk’s role in diabetes and weight management treatments, as well as regulatory and competitive headlines that keep the company in the spotlight. Together, these factors help explain why the share price has been so reactive, as investors reassess expectations and risk.
- Against that…
Source link
